Incidence of cervical precancers among HIV-seropositive women.
Incidence of cervical precancers among HIV-seropositive women.
复制标题
DOI:
10.1016/j.ajog.2014.12.003
复制
发表时间:
2015-05
影响因子:
9.8
通讯作者:
Strickler, Howard D.
中科院分区:
文献类型:
--
作者:
Massad, L. Stewart;Xie, Xianhong;D'Souza, Gypsyamber;Darragh, Teresa M.;Minkoff, Howard;Wright, Rodney;Colie, Christine;Sanchez-Keeland, Lorraine;Strickler, Howard D.
关键词:
To estimate the impact of HIV infection on the incidence of high grade cervical intraepithelial neoplasia (CIN). HIV seropositive and comparison seronegative women enrolled in a prospective U.S. cohort study were followed with semiannual Pap testing, with colposcopy for any abnormality. Histology results were retrieved to identify CIN3+ (CIN3, adenocarcinoma in situ, and cancer and CIN2+ (CIN2 and CIN3+). Annual detection rates were calculated and risks compared using Cox analysis. Median follow-up (IQR) was 11.0 (5.4–17.2) years for HIV seronegative and 9.9 (2.5–16.0) for HIV seropositive women. CIN3+ was diagnosed in 139 (5%) HIV seropositive and 19 (2%) seronegative women (P < 0.0001), with CIN2+ in 316 (12%) and 34 (4%) (P < 0.0001). The annual CIN3+ detection rate was 0.6/100 person-years in HIV seropositive women and 0.2/100 person years in seronegative women (P < 0.0001). The CIN3+ detection rate fell after the first two years of study, from 0.9/100 person-years among HIV seropositive women to 0.4/100 person-years during subsequent follow-up (P < 0.0001). CIN2+ incidence among these women fell similarly with time, from 2.5/100 person-years during the first two years after enrollment to 0.9/100 person-years subsequently (p < 0.0001). In Cox analyses controlling for age, the hazard ratio for HIV seropositive women with CD4 counts <200/cmm compared to HIV seronegative women was 8.1 (95% C.I. 4.8, 13.8) for CIN3+ and 9.3 (95% C.I. 6.3, 13.7) for CIN2+ (P < 0.0001). Although HIV seropositive women have more CIN3+ than seronegative women, CIN3+ is uncommon and becomes even less frequent after initiation of regular cervical screening.
登录
查看更多内容
影响因子:
3.7
作者:
Darragh, Teresa M.;Colgan, Terence J.;Wilbur, David C.
通讯作者:
Wilbur, David C.
影响因子:
5.4
作者:
Barkan, SE;Melnick, SL;Feldman, J
通讯作者:
Feldman, J
影响因子:
120.7
作者:
Keller, Marla J.;Burk, Robert D.;Strickler, Howard D.
通讯作者:
Strickler, Howard D.
影响因子:
7.2
作者:
Massad, LS;Evans, CT;Passaro, DJ
通讯作者:
Passaro, DJ
影响因子:
10.3
作者:
Palefsky, JM;Minkoff, H;Burk, R
通讯作者:
Burk, R